More than 1200 new projects funded in latest ARC round
02 October, 2002 by Iain ScottA total of 1252 new projects are to receive Australian Research Council (ARC) funding, totalling $289.5 million over the next three years, it was announced today.
Better believe it - science isn't natural
30 September, 2002 by Iain ScottIt was, as he admitted himself, an unusual topic with which to kick off a cell biology meeting. But Prof Lewis Wolpert's plenary lecture, 'The Biology of Belief', which he gave at the ComBio 2002 meeting in Sydney this morning, straddled clinical research, anthropology, ancient history and technology -- setting the tone for the breadth of research that was to come at the conference.
Over 1000 in attendance for ComBio kick-off
30 September, 2002 by Iain ScottMore than 1000 delegates have rolled up for this year's ComBio conference at Sydney's Darling Harbour, according to organisers.
Iatia MD Cussinet resigns
26 September, 2002 by Melissa TrudingerThe resignation of Iatia managing director Philippe Cussinet will not impact the growth of the company, according to CEO Brian Powell.
AusBiotech to probe industry's insurance woes
25 September, 2002 by Melissa TrudingerRumours that biotechnology companies are finding it hard to renew professional indemnity insurance policies have led industry association AusBiotech to investigate the potential for problems.
VC tax reforms could assist biotech
25 September, 2002 by Pete YoungThe Federal government is implementing changes to venture capital tax structures which carry positive long-term implications for biotech companies seeking risk capital.
Lack of vision critical: FASTS report
24 September, 2002 by Graeme O'NeillAustralia's peak council for science and technology delivered a state-of-the-nation report to Federal Parliament this week that shows Australia slipping further off the pace among industrialised nations in its performance in science, technology and higher education.
Feds to fine-tune science blueprint
24 September, 2002 by Graeme O'NeillOnly 18 months into its $2.9 billion Backing Australia's Ability program, the Federal government is looking to adjust its innovation blueprint -- and that could involve culling some elements that aren't working, Science Minister Peter McGauran has foreshadowed.
Weak spots exposed by commercialisation survey
20 September, 2002 by Pete YoungA landmark survey of the commercialisation track record by Australia's publicly-funded research bodies shows worrying weak spots in a generally favourable picture.
US patent will soak up the red ink at Peptech: Kwik
20 September, 2002 by David BinningAustralian biotech hopeful Peptech got the green light from the US patents office for its Tumour Necrosis Factor Antibodies technique this week.
Product rollout keeps VRI confident despite loss
20 September, 2002 by Pete YoungNatural health products company VRI Biomedical has reason to be upbeat about its future despite posting the largest annual loss in its short history.
Tax offset to hurt small biotechs
20 September, 2002 by Graeme O'NeillThe Federal government's 'Backing Australia's Ability' package seems to have backed right over small biotechnology companies, crushing their hopes for substantial cash rebates on their R&D expenditure.
CAREERS SPECIAL: Digging for talent
17 September, 2002 by Pete YoungAustralia's growing biotech industry has sparked recruitment sector interest. Pete Young surveys the scene
CAREER SPECIAL: Risk and reward
17 September, 2002 by Graeme O'NeillGraeme O'Neill reports on the hiring challenges faced by small-to-medium Australian biotechs
Nanotech expert to assist Chief Scientist
16 September, 2002 by Graeme O'NeillCSIRO nanotechnology expert Dr Vijoleta Braach-Maksvytis has been appointed to a new, part-time role as head of the Office of the Chief Scientist, to assist Chief Scientist Dr Robin Batterham.
